As of today (2024-04-23), Organon's share price is $18.00.
Organon's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $3.12. Hence, Organon's Price-to-Operating-Cash-Flow Ratio for today is 5.78.
The historical rank and industry rank for Organon's Price-to-Operating-Cash-Flow or its related term are showing as below:
OGN'
s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 2.48 Med: 6.11 Max: 12.65
Current: 5.76
During the past 6 years, Organon's highest Price-to-Operating-Cash-Flow Ratio was 12.65. The lowest was 2.48. And the median was 6.11.
Organon's Cash Flow from Operations per share for the
three
months ended in Dec. 2023 was $1.55.
Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $3.12.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Organon was -7.30% per year.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -28.80% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -27.20% per year.
During the past 6 years, Organon's highest 3-Year average Operating Cash Flow per Share Growth Rate was -12.80% per year. The lowest was -32.50% per year. And the median was -28.80% per year.
Organon Price-to-Operating-Cash-Flow Historical Data
The historical data trend for Organon's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
|
Organon Annual Data
|
|
Trend |
Dec18 |
Dec19 |
Dec20 |
Dec21 |
Dec22 |
Dec23 |
| Price-to-Operating-Cash-Flow |
|
|
- |
- |
3.15 |
8.31 |
4.62 |
|
Organon Quarterly Data
|
|
Dec18 |
Dec19 |
Mar20 |
Jun20 |
Sep20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
Sep22 |
Dec22 |
Mar23 |
Jun23 |
Sep23 |
Dec23 |
| Price-to-Operating-Cash-Flow |
|
|
|
|
|
|
|
|
|
|
|
|
|
8.31 |
7.07 |
7.33 |
6.64 |
4.62 |
Competitive Comparison
For the Drug Manufacturers - General subindustry, Organon's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Organon Price-to-Operating-Cash-Flow Distribution
For the Drug Manufacturers industry and Healthcare sector, Organon's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Organon's Price-to-Operating-Cash-Flow falls into.
Organon Price-to-Operating-Cash-Flow Calculation
Organon's Price-to-Operating-Cash-Flow ratio for today is calculated as
| Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
| = | 18.00 | / | 3.115 |
| = | 5.78 |
Organon's Share Price of today is $18.00.
Organon's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $3.12.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
Organon (Organon) Business Description
Traded in Other Exchanges
Address
30 Hudson Street, Floor 33, Jersey City, NJ, USA, 07302
Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars, and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada.
Executives
| Kirke Weaver |
officer: Gen. Counsel & Corp. Secy. |
30 HUDSON STREET, FLOOR 33, JERSEY CITY NJ 07302 |
| Ma. Fatima Francisco |
director |
ONE PROCTER & GAMBLE PLAZA, CINCINNATI OH 45202 |
| Deborah H Telman |
officer: General Counsel |
2000 GALLOPING HILL ROAD, KENILWORTH NJ 07033 |
| Kathryn Dimarco |
officer: Corporate Controller |
30 HUDSON STREET, FLOOR 33, JERSEY CITY NJ 07302 |
| Susanne Fiedler |
officer: Chief Commercial Officer |
2000 GALLOPING HILL ROAD, KENILWORTH NJ 07033 |
| Vittorio Nisita |
officer: Head of Global Business Svcs |
2000 GALLOPING HILL ROAD, KENILWORTH NJ 07033 |
| Morrissey Joseph T. Jr. |
officer: Head of Manufacturing |
2000 GALLOPING HILL ROAD, KENILWORTH NJ 07033 |
| Aaron Falcione |
officer: Chief Human Resources Officer |
2000 GALLOPING HILL ROAD, KENILWORTH NJ 07033 |
| Deborah R Leone |
director |
2000 GALLOPING HILL ROAD, KENILWORTH NJ 07033 |
| Martha E Mcgarry |
director |
2000 GALLOPING HILL ROAD, KENILWORTH NJ 07033 |
| Phillip Ozuah |
director |
30 HUDSON STREET, FLOOR 33, JERSEY CITY NJ 07302 |
| Geralyn S Ritter |
officer: Hd of Ext. Affairs and ESG |
2000 GALLOPING HILL ROAD, KENILWORTH NJ 07033 |
| Sandra Milligan |
officer: Head of Research & Development |
2000 GALLOPING HILL ROAD, KENILWORTH NJ 07033 |
| Cynthia M Patton |
director |
ONE AMGEN CENTER DRIVE, THOUSAND OAKS CA 91320-1799 |
| Alan Ezekowitz |
director |
C/O FULCRUM THERAPEUTICS, INC., 26 LANDSDOWNE STREET, CAMBRIDGE MA 02139 |
Organon (Organon) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
OGN has been successfully added to your